Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454.

Bellier B, Crété D, Million ME, Beslot F, Bado A, Garbay C, Daugé V.

Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):404-13. Epub 2004 Oct 8.

PMID:
15480577
2.

In vivo properties of thiol inhibitors of the three vasopeptidases NEP, ACE and ECE are improved by introduction of a 7-azatryptophan in P2' position.

Inguimbert N, Poras H, Dhotel H, Beslot F, Scalbert E, Bennejean C, Renard P, Fournié-Zaluski MC, Roques BP.

J Pept Res. 2004 Feb;63(2):99-107.

PMID:
15009531
3.

Alpha-lactalbumin-enriched diets enhance serotonin release and induce anxiolytic and rewarding effects in the rat.

Orosco M, Rouch C, Beslot F, Feurte S, Regnault A, Dauge V.

Behav Brain Res. 2004 Jan 5;148(1-2):1-10.

PMID:
14684242
4.

N-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidases (NEP, ACE, ECE): In vitro and In vivo activities.

Inguimbert N, Poras H, Teffo F, Beslot F, Selkti M, Tomas A, Scalbert E, Bennejean C, Renard P, Fournié-Zaluski MC, Roques BP.

Bioorg Med Chem Lett. 2002 Aug 5;12(15):2001-5.

PMID:
12113828
5.

Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.

Pommier B, Beslot F, Simon A, Pophillat M, Matsui T, Dauge V, Roques BP, Noble F.

J Neurosci. 2002 Mar 1;22(5):2005-11.

6.

Behavioral profile of CCK2 receptor-deficient mice.

Daugé V, Sebret A, Beslot F, Matsui T, Roques BP.

Neuropsychopharmacology. 2001 Nov;25(5):690-8.

7.
8.

Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect.

Valverde O, Noble F, Beslot F, Daugé V, Fournié-Zaluski MC, Roques BP.

Eur J Neurosci. 2001 May;13(9):1816-24.

PMID:
11359533
9.

Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum.

Tzavara ET, Valjent E, Firmo C, Mas M, Beslot F, Defer N, Roques BP, Hanoune J, Maldonado R.

Eur J Neurosci. 2000 Mar;12(3):1038-46.

PMID:
10762335
10.

Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors.

Valverde O, Ledent C, Beslot F, Parmentier M, Roques BP.

Eur J Neurosci. 2000 Feb;12(2):533-9.

PMID:
10712632
11.

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Böhme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M.

Science. 1999 Jan 15;283(5400):401-4.

12.

Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.

Gonzalez W, Beslot F, Laboulandine I, Fournié-Zaluski MC, Roques BP, Michel JB.

J Pharmacol Exp Ther. 1996 Aug;278(2):573-81.

PMID:
8768706
13.
14.

Uptake of 5-hydroxytryptamine in rat isolated atria.

el Rawadi C, Heimburger M, Davy M, Midol-Monnet M, Beslot F, Cohen Y.

Gen Pharmacol. 1992 Jul;23(4):613-7.

PMID:
1383073
15.

Modulation of noradrenergic transmission in the rat isolated portal vein: role of prejunctional alpha 2-adrenoceptors and beta-adrenoceptors.

Ortiz de Urbina AV, Davy M, Midol-Monnet M, Heimburger M, Beslot F, Cohen Y.

Gen Pharmacol. 1992 Jul;23(4):763-7.

PMID:
1356878
16.

Cardiovascular effects of intracerebroventricular injections of (+/-)-nebivolol and its enantiomers--a comparison with those of metoprolol in the rat.

Midol-Monnet M, Davy M, Heimburger M, Beslot F, Cohen Y.

J Pharm Pharmacol. 1991 Jul;43(7):504-9.

PMID:
1682465
17.

Presynaptic beta-adrenoceptors in rat atria: evidence for the presence of stereoselective beta 1-adrenoceptors.

Heimburger M, Montero MJ, Fougeres V, Beslot F, Davy M, Midol-Monnet M, Cohen Y.

Br J Pharmacol. 1989 Sep;98(1):211-7.

18.

Study on the mechanism of 5-HT-induced tachycardia in the pithed rat.

Midol-Monnet M, Heimburger M, Davy M, Beslot F, Cohen Y.

Gen Pharmacol. 1989;20(6):755-8.

PMID:
2480263
19.

Peripheral and central cardiovascular effects of ketanserin in conscious normotensive rats.

Davy M, Midol-Monnet M, Heimburger M, Beslot F, Cohen Y.

Arch Int Pharmacodyn Ther. 1987 Dec;290(2):193-206.

PMID:
3128194
20.

[Autonomic cardiovascular regulation and permanent catheterization in normotensive conscious (WKY) and spontaneously hypertensive (SHR) rats].

Midol-Monnet M, Heimburger M, Davy M, Beslot F, Cohen Y.

C R Seances Soc Biol Fil. 1987;181(5):560-6. French.

PMID:
2966659
21.

Tissue distribution of acebutolol in mature normotensive and stroke-prone spontaneously hypertensive rats.

Midol-Monnet M, Heimburger M, Davy M, Beslot F, Cohen Y.

Comp Biochem Physiol C. 1987;87(1):83-6.

PMID:
2885145
22.

Chronic subcutaneous treatment with acebutolol: haemodynamic effects and metabolism in spontaneously hypertensive rats.

Heimburger M, Davy M, Midol-Monnet M, Beslot F, Cohen Y.

J Pharm Pharmacol. 1986 Sep;38(9):699-702.

PMID:
2877074
23.

Cardiovascular effects of drugs acting on the autonomous nervous system, in awake, normotensive and hypertensive rats.

Davy M, Heimburger M, Midol-Monnet M, Beslot F, Cohen Y.

Arch Int Pharmacodyn Ther. 1985 Mar;274(1):31-46.

PMID:
4015261
24.

Acute haemodynamic effects and tissue distribution of acebutolol in normotensive and spontaneously hypertensive rats.

Midol-Monnet M, Heimburger M, Davy M, Beslot F, Wepierre J, Cohen Y, Barre J.

Comp Biochem Physiol C. 1985;82(1):75-9.

PMID:
2865078
25.

[Localization of 14 C epinephrine in the guinea pig in correlation with eye and skin pigmentation].

Wepierre J, Beslot F.

C R Seances Soc Biol Fil. 1973;167(5):670-4. French. No abstract available.

PMID:
4787824

Supplemental Content

Loading ...
Support Center